Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Profusa ( (PFSA) ) has shared an update.
On August 19, 2025, Profusa announced the appointment of Peter O’Rourke, former Acting U.S. Secretary of Veterans Affairs, as Lead Independent Director, and Fred Knechtel, a seasoned financial executive, as CFO. These leadership changes come as Profusa prepares to commercialize its biosensor platform, aiming to enhance its market position and drive growth. O’Rourke’s extensive experience in healthcare systems and Knechtel’s financial expertise are expected to strengthen Profusa’s path to commercialization and maximize shareholder value.
More about Profusa
Profusa, Inc., based in Berkeley, California, is a commercial stage digital health company focused on developing tissue-integrated sensors for continuous biochemical monitoring. The company aims to provide personalized, actionable medical-grade data through its biosensors and intelligent data platform.
Average Trading Volume: 5,640,545
Technical Sentiment Signal: Sell
Current Market Cap: $16.37M
Learn more about PFSA stock on TipRanks’ Stock Analysis page.